OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Simulating the outcome of amyloid treatments in Alzheimer's disease from imaging and clinical data
Clément Abi Nader, Nicholas Ayache, Giovanni B. Frisoni, et al.
Brain Communications (2021) Vol. 3, Iss. 2
Open Access | Times Cited: 14
Clément Abi Nader, Nicholas Ayache, Giovanni B. Frisoni, et al.
Brain Communications (2021) Vol. 3, Iss. 2
Open Access | Times Cited: 14
Showing 14 citing articles:
Data-driven modelling of neurodegenerative disease progression: thinking outside the black box
Alexandra L. Young, Neil P. Oxtoby, Sara Garbarino, et al.
Nature reviews. Neuroscience (2024) Vol. 25, Iss. 2, pp. 111-130
Closed Access | Times Cited: 27
Alexandra L. Young, Neil P. Oxtoby, Sara Garbarino, et al.
Nature reviews. Neuroscience (2024) Vol. 25, Iss. 2, pp. 111-130
Closed Access | Times Cited: 27
The Alzheimer's Disease Neuroimaging Initiative in the era of Alzheimer's disease treatment: A review of ADNI studies from 2021 to 2022
Dallas P. Veitch, Michael W. Weiner, Melanie J. Miller, et al.
Alzheimer s & Dementia (2023) Vol. 20, Iss. 1, pp. 652-694
Open Access | Times Cited: 35
Dallas P. Veitch, Michael W. Weiner, Melanie J. Miller, et al.
Alzheimer s & Dementia (2023) Vol. 20, Iss. 1, pp. 652-694
Open Access | Times Cited: 35
Analysis of Cerebrospinal Fluid, Plasma β-Amyloid Biomarkers, and Cognition from a 2-Year Phase 2 Trial Evaluating Oral ALZ-801/Valiltramiprosate in APOE4 Carriers with Early Alzheimer’s Disease Using Quantitative Systems Pharmacology Model
John A. Hey, Yongxin Yu, Susan Abushakra, et al.
Drugs (2024) Vol. 84, Iss. 7, pp. 825-839
Open Access | Times Cited: 3
John A. Hey, Yongxin Yu, Susan Abushakra, et al.
Drugs (2024) Vol. 84, Iss. 7, pp. 825-839
Open Access | Times Cited: 3
Generative AI unlocks PET insights: brain amyloid dynamics and quantification
Matías Nicolás Bossa, Akshaya Ganesh Nakshathri, Abel Díaz Berenguer, et al.
Frontiers in Aging Neuroscience (2024) Vol. 16
Open Access | Times Cited: 2
Matías Nicolás Bossa, Akshaya Ganesh Nakshathri, Abel Díaz Berenguer, et al.
Frontiers in Aging Neuroscience (2024) Vol. 16
Open Access | Times Cited: 2
A multidimensional ODE-based model of Alzheimer’s disease progression
Matías Nicolás Bossa, Hichem Sahli
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 6
Matías Nicolás Bossa, Hichem Sahli
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 6
Riemannian Metric Learning for Progression Modeling of Longitudinal Datasets
Benoît Sauty, Stanley Durrleman
2022 IEEE 19th International Symposium on Biomedical Imaging (ISBI) (2022), pp. 1-5
Open Access | Times Cited: 6
Benoît Sauty, Stanley Durrleman
2022 IEEE 19th International Symposium on Biomedical Imaging (ISBI) (2022), pp. 1-5
Open Access | Times Cited: 6
Machine Learning for Alzheimer’s Disease and Related Dementias
Marc Modat, David M. Cash, Liane S. Canas, et al.
Neuromethods (2023), pp. 807-846
Open Access | Times Cited: 3
Marc Modat, David M. Cash, Liane S. Canas, et al.
Neuromethods (2023), pp. 807-846
Open Access | Times Cited: 3
Quantifying the Growth of Glioblastoma Tumors Using Multimodal MRI Brain Images
Anisha Das, Shengxian Ding, Rongjie Liu, et al.
Cancers (2023) Vol. 15, Iss. 14, pp. 3614-3614
Open Access | Times Cited: 2
Anisha Das, Shengxian Ding, Rongjie Liu, et al.
Cancers (2023) Vol. 15, Iss. 14, pp. 3614-3614
Open Access | Times Cited: 2
Data-Driven Disease Progression Modeling
Neil P. Oxtoby
Neuromethods (2023), pp. 511-532
Open Access | Times Cited: 2
Neil P. Oxtoby
Neuromethods (2023), pp. 511-532
Open Access | Times Cited: 2
SimulAD: a dynamical model for personalized simulation and disease staging in Alzheimer’s disease
Clément Abi Nader, Federica Ribaldi, Giovanni B. Frisoni, et al.
Neurobiology of Aging (2022) Vol. 113, pp. 73-83
Open Access | Times Cited: 4
Clément Abi Nader, Federica Ribaldi, Giovanni B. Frisoni, et al.
Neurobiology of Aging (2022) Vol. 113, pp. 73-83
Open Access | Times Cited: 4
Development of a quantitative semi‐mechanistic model of Alzheimer's disease based on the amyloid/tau/neurodegeneration framework (the Q‐ATN model)
Norman A. Mazer, Carsten Hofmann, Dominik Lott, et al.
Alzheimer s & Dementia (2022) Vol. 19, Iss. 6, pp. 2287-2297
Open Access | Times Cited: 4
Norman A. Mazer, Carsten Hofmann, Dominik Lott, et al.
Alzheimer s & Dementia (2022) Vol. 19, Iss. 6, pp. 2287-2297
Open Access | Times Cited: 4
Non-parametric ODE-Based Disease Progression Model of Brain Biomarkers in Alzheimer’s Disease
Matías Nicolás Bossa, Abel Díaz Berenguer, Hichem Sahli
Lecture notes in computer science (2022), pp. 95-103
Closed Access | Times Cited: 3
Matías Nicolás Bossa, Abel Díaz Berenguer, Hichem Sahli
Lecture notes in computer science (2022), pp. 95-103
Closed Access | Times Cited: 3
Dynamic associations between tau aggregation, atrophy, and cognitive decline in Alzheimer's disease
Ellen H. Singleton, Niklas Mattsson, Alexa Pichet Binette, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Ellen H. Singleton, Niklas Mattsson, Alexa Pichet Binette, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
A multidimensional ODE-based model of Alzheimer's disease progression
Matías Nicolás Bossa, Hichem Sahli
Research Square (Research Square) (2022)
Open Access | Times Cited: 1
Matías Nicolás Bossa, Hichem Sahli
Research Square (Research Square) (2022)
Open Access | Times Cited: 1
